AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces the appointment of Mr. Robert Schenk as National Sales Director and the launch of AMP’s nationwide Marketing Sales Campaign for branded medical cannabis products.
Mr. Schenk, who will oversee the development and execution of AMP’s sales and marketing strategies and lead our nationwide sales team, officially joins AMP today. Mr. Schenk brings over 20 years of experience in the pharmaceutical industry to AMP and was most recently, Regional Manager of Canopy Growth Germany GmbH, a subsidiary of Canopy Growth Corporation (Nasdaq: CGC), where he established, built and lead Canopy’s nationwide sales team in Germany.
AMP also launched its marketing sales campaign for AMP’s line of branded medical cannabis products, which includes cannabis flower products: Aphria Strong 9, Bedrocan and Bediol Cannabis Floss, as well as extracts: Little Green Pharma Classic 20:5 and Classic 10:10. AMP will be launching its cannabis flower product AMP Classic 18/1 Primary in May 2021 supplied by Schroll Medical and additional AMP branded flower and extract products from Canada as well as Australia during the second half of the year. German doctors and pharmacists can find further information about AMP’s medical cannabis products at www.amp-eu.com/doccheck-login/.
AMP’s nationwide sales team includes highly capable and accomplished pharmaceutical sales representatives in Stade, Cologne, Nordhausen and Speyer who are selling Aphria and AMP’s catalogue of medical cannabis products to over 13,000 pharmacies under AMP’s co-promotion agreement with CC Pharma, a national pharmaceutical distributor and a wholly-owned subsidiary of Aphria Inc. (Nasdaq: APHA).
Photo: AMP’s management and sales team. You can view this photo at: https://twitter.com/AMP_Cannabis/status/1379631320956071936
AMP and CC Pharma are jointly training their sales teams on how to advance knowledge among doctors and best practices fulfilling medical cannabis prescriptions and how medical cannabis can help in patient therapy and ensuring that pharmacies nationwide have access to AMP’s selection of medical cannabis products.
To advance the benefits of medical cannabis therapy knowledge, AMP and CC Pharma are holding education seminars across Germany for doctors and pharmacists.
AMP also launched its new website (www.amp-eu.com) which provides information about medical cannabis and a secure portal for doctors and pharmacists for information about our products and how to contact our sales team.
Dr. Stefan Feuerstein, President and Director of AMP, commented, “Our strategy is to focus on servicing our customers and commit to advance medical cannabis therapy for the patient. AMP and CC Pharma are committed to this strategy and are advancing education about the health benefits of cannabis and best practices for patient therapy in the medical community through our joint education seminars for doctors and pharmacists”.
Robert Schenk, National Sales Director of AMP, commented, “AMP has been able to assemble a wide range of leading medical cannabis flower and extract brands products for sale during challenging times during the Corona pandemic. Our nationwide sales team has been trained to help educate doctors about the benefits of medical cannabis in patient therapy.”